COMPARISON OF 3 CELL-CYCLE ASSOCIATED ANTIGENS AS MARKERS OF PROLIFERATIVE ACTIVITY AND PROGNOSIS IN BREAST-CARCINOMA

被引:23
|
作者
GILLETT, CE [1 ]
BARNES, DM [1 ]
CAMPLEJOHN, RS [1 ]
机构
[1] ST THOMAS HOSP,DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND
关键词
D O I
10.1136/jcp.46.12.1126
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The staining patterns obtained with two antibodies against proliferating cell nuclear antigen (PC10 and 19A2) and another cell cycle associated antibody (KiS1) were compared with each other and with a number of established prognostic markers of breast carcinoma. Although PC10 and 19A2 staining patterns were similar, only the latter was significantly associated with KiS1 antibody staining. These findings suggest that the two PCNA antibodies detect different epitopes. KiS1 was the only antibody to show an association with S phase fraction measured by flow cytometry (p < 0.001). It was also associated with histological grade (p = 0.003), oestrogen receptors (p = 0.045), and DNA index (p = 0.007). PC10 showed no association with any of the markers of prognosis, while 19A2 was associated with histological grade (p = 0.017) and oestrogen receptors (p = 0.043). The two PCNA antibodies do not seem to be of value in measuring proliferative activity nor do they seem to be associated with established markers of prognosis in breast cancer.
引用
收藏
页码:1126 / 1128
页数:3
相关论文
共 50 条
  • [21] DNA amplifications and aneuploidy, high proliferative activity and impaired cell cycle control characterize breast carcinomas with poor prognosis
    Blegen, H
    Will, JS
    Ghadimi, BM
    Nash, HP
    Zetterberg, A
    Auer, G
    Ried, T
    ANALYTICAL CELLULAR PATHOLOGY, 2003, 25 (03) : 103 - 114
  • [22] CpG island methylator phenotype of cell-cycle regulators associated with TNM stage and poor prognosis in patients with oesophageal squamous cell carcinoma
    Ling, Yang
    Huang, Guoliang
    Fan, Lieying
    Wei, Lixin
    Zhu, Jing
    Liu, Yongping
    Zhu, Changtai
    Zhang, Changsong
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (03) : 246 - 251
  • [23] HETEROGENEITY IN THE EXPRESSION OF HLA AND TUMOR-ASSOCIATED ANTIGENS BY SURGICALLY REMOVED AND CULTURED BREAST-CARCINOMA CELLS
    NATALI, PG
    GIACOMINI, P
    BIGOTTI, A
    IMAI, K
    NICOTRA, MR
    NG, AK
    FERRONE, S
    CANCER RESEARCH, 1983, 43 (02) : 660 - 668
  • [24] OVERALL AND DISEASE FREE SURVIVAL IN BREAST-CARCINOMA - COMPARISON OF 3 GRADING SYSTEMS
    WOLD, LE
    WIEAND, HS
    INGLE, JN
    BARLOW, J
    EVERSON, LK
    LABORATORY INVESTIGATION, 1988, 58 (01) : A105 - A105
  • [25] OVERALL AND DISEASE FREE SURVIVAL IN BREAST-CARCINOMA - COMPARISON OF 3 GRADING SYSTEMS
    WOLD, LE
    WIEAND, HS
    INGLE, JN
    BARLOW, J
    EVERSON, LK
    MODERN PATHOLOGY, 1988, 1 (01) : A105 - A105
  • [26] New markers for breast carcinoma-associated antigen in comparison with CA 15-3
    vanDalen, A
    ANTICANCER RESEARCH, 1996, 16 (4B) : 2339 - 2343
  • [27] ASSESSMENT OF TUMOR PROLIFERATIVE ACTIVITY (TPA) IN NODE-POSITIVE BREAST-CARCINOMA BY USING IMMUNOSTAINING (IMS) FOR PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA)
    SAHIN, A
    SNEIGE, N
    RO, J
    ORDONEZ, N
    KAU, S
    HORTOBAGYI, G
    AYALA, A
    LABORATORY INVESTIGATION, 1991, 64 (01) : A14 - A14
  • [28] EVALUATION OF MITOTIC-ACTIVITY AS COMPONENT OF HISTOLOGICAL GRADE AND ITS CONTRIBUTION TO PROGNOSIS IN PRIMARY BREAST-CARCINOMA
    MANN, R
    ELSTON, CW
    HUNTER, S
    BAYNES, S
    ELLIS, IO
    LOWE, J
    BLAMEY, RW
    JOURNAL OF PATHOLOGY, 1985, 146 (03): : A271 - A271
  • [29] CA 15-3 AND CEA AS TUMOR-MARKERS IN THE DIAGNOSIS OF RECURRENT BREAST-CARCINOMA
    ENGEL, K
    SCHMID, H
    HANKE, J
    KAUFMANN, M
    MULLER, A
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1988, 48 (05) : 309 - 312
  • [30] THE PARAMETERS OF CELL-CYCLE AND PROLIFERATIVE ACTIVITY IN TISSUES OF CHLORIOALLANTOIS AT DIFFERENT STAGES OF THE CHICK-EMBRYO DEVELOPMENT
    DROBOT, GP
    TSITOLOGIYA, 1985, 27 (06): : 720 - 725